Abstract-Angiotensin II (Ang II), via its interaction with the angiotensin type 1 (AT 1 ) receptor subtype, causes enhanced stimulation of norepinephrine (NE) neuromodulation. This involves increased transcription of NE transporter, tyrosine hydroxylase, and dopamine -hydroxylase genes in Wistar-Kyoto rat (WKY) brain neurons. AT 1 receptor-mediated regulation of certain signaling events (such as activation of the Ras-Raf-1-mitogen activated protein (MAP) kinase signaling pathway, nuclear translocation of transcription factors such as Fos and Jun, and the interactions of these factors with AP-1 binding sites) is involved in this NE neuromodulation (Lu et al. J Cell Biol. 1996;135:1609 -1617 Key Words: angiotensin Ⅲ intracellular signaling Ⅲ MAP kinase Ⅲ neurons Ⅲ norepinephrine Ⅲ rats, inbred SHR B rain angiotensin II (Ang II) plays a key role in the central control of blood pressure (BP). This action is initiated by the interaction of Ang II with the Ang II subtype 1 (AT 1 ) receptor that is localized in the cardioregulatory-relevant areas of the brain. [1][2][3][4][5][6] The physiological mechanisms of the regulation of Ang II of BP control implicate the stimulation of sympathetic pathways involving catecholamines, the dampening of baroreflexes, and the release of vasopressin.
1-9The significance of the brain angiotensin system and the AT 1 receptor in the control of BP is further underscored by studies with the spontaneously hypertensive rat (SHR, a genetic model of human essential hypertension) and with the renintransgenic rat model of hypertension. 10,11 For example, studies with SHR demonstrate that this model expresses a hyperactive brain angiotensin system as a result of an increased AT 1 receptor gene expression. 6,12,13 In addition, Ang II-mediated regulation of catecholamine turnover has also been heightened in the SHR.6,9,14 -16 Similar hyperactivity of the brain angiotensin system has recently been reported for the renintransgenic rat.17 Finally, interruption in the hyperactivity of this system by either pharmacological or genetic means in the SHR normalizes BP, further confirming the involvement of brain angiotensin in the development and establishment of high BP and hypertension. 6,18 -20 Despite excellent physiological studies defining the involvement of catecholamines and vasopressin in Ang II-mediated control of BP, limited information is available about the cellular and molecular mechanisms of these physiological actions. Our group has been exceedingly interested in this aspect and had established neuronal cells in primary culture from the hypothalamus/brain stem areas of 1-day-old rats as an in vitro model to study the cellular mechanism of Ang II actions and the molecular basis of a hyperactive brain angiotensin system in SHR. 4,6 These studies have revealed that a hyperactive brain angiotensin system expressed in vivo could be maintained in neuronal cell cultures. 6 We have established, with the use of these neuronal cultures, that the interaction of Ang II with the AT 1 receptor initiat...